(Q40430854)

20 September 2017

title

Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector (English)

1 reference

20 September 2017

5

1 reference

20 September 2017

6

Luigi Naldini

0 references

Mario Amendola

object named as

Mario Amendola

2

0 references

author name string

Elisa Vigna

1

1 reference

20 September 2017

Fabrizio Benedicenti

3

1 reference

20 September 2017

Andrew D Simmons

4

1 reference

20 September 2017

publication date

1 May 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

11

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

763-775

1 reference

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Gene therapy progress and prospects: transcription regulatory systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Global analysis of cellular transcription following infection with an hiv-based vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Lentiviral vectors: regulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Gene transfer as an approach to treating hemophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Transactivator and structurally optimized inducible lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Regulation of human factor IX expression using doxycycline-inducible gene expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Tightly regulated long-term erythropoietin expression in vivo using tet-inducible recombinant adeno-associated viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

A third-generation lentivirus vector with a conditional packaging system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.11.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2004.11.017

1 reference

20 September 2017

1 reference